Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly
A multicentre, prospective, open label study of acromegalic patients evaluating the efficacy and safety of different dose-intervals of Lanreotide Autogel 120mg according to international standards and compared to previous treatment with Octreotide LAR 10, 20 or 30 mg.
Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly
- 06 novembre 2024 - 1 mn de lecture
A multicentre, prospective, open label study of acromegalic patients evaluating the efficacy and safety of different dose-intervals of Lanreotide Autogel 120mg according to international standards and compared to previous treatment with Octreotide LAR 10, 20 or 30 mg.
En rapport Clinical Trials
06 novembre 2024
1 mn de lecture
Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis
06 novembre 2024
1 mn de lecture
Efficacy And Safety Of Dysport In The Treatment Of Upper Limb Spasticity In Children
06 novembre 2024
1 mn de lecture
Dysport® Adult Upper Limb Spasticity Extension Study
06 novembre 2024
1 mn de lecture
Safety and Efficacy Study of Dysport RU and Glabellar Lines
06 novembre 2024
1 mn de lecture
Dysport® Adult Upper Limb Spasticity
06 novembre 2024
1 mn de lecture
Study Comparing Short Term Efficacy of Dysport and Dysport NG to Placebo, and to Assess Efficacy and Safety of Dysport NG of Subjects With Cervical...
06 novembre 2024
1 mn de lecture
Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment
06 novembre 2024
1 mn de lecture
Open-label Extension Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia
06 novembre 2024
1 mn de lecture
Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome
06 novembre 2024
1 mn de lecture